Cash-pay compounded GLP-1 plans

Yucca Health review

Yucca offers stated monthly and prepaid GLP-1 plans with no separate membership fee. Its $69 semaglutide rate is billed as $828 every twelve months; the conditional refund promise has a special deadline for annual plans.

Check your care options.

Confirm the medication, clinical access and recurring bill for your own plan.

Visit Yucca HealthOfficial provider website. No affiliate relationship is currently listed.

A fit for

Cash-pay buyers who can compare a defined billing period and understand the conditional refund terms before enrollment.

  • Monthly, six-month and annual plan charges are separately listed.
  • The product description includes consultation, injection kit and shipping.
  • The detailed offer terms identify a separate annual-plan claim deadline.

Tradeoffs to understand

Readers seeking insurance navigation, an approved branded product or a no-conditions money-back trial.

  • The lowest monthly equivalent requires an annual charge.
  • The guarantee FAQ differs from the detailed terms on logging and pauses.
  • Prescription issuance ends the ordinary cancellation refund.
In this review

The annual rate belongs beside the annual charge

Yucca is a useful cash-pay comparison when the buyer wants a stated medication-and-service plan rather than a separate membership bill. Semaglutide is listed at $89 monthly, $450 every six months or $828 every twelve months. Tirzepatide is $139 monthly, $750 every six months or $1,428 annually. The lowest semaglutide equivalent is $69 per month; the actual annual invoice is $828. [1] [2]

Consultation, an injection kit and shipping are included in the product description. The plans renew at the chosen interval. Financing installments, if selected, do not shorten that commitment. A buyer who values the option to change service soon should compare the monthly plan on its own merits rather than treating the annual equivalent as a universally better price. [1] [3] [5]

The guarantee needs the detailed agreement

Yucca’s six-month promise applies to qualifying GLP-1 injectable plans started on or after September 18, 2026 and requires no weight loss against the logged starting weight. It is conditional commercial protection, not a promise of a medical result. The detailed terms add a crucial annual-plan exception: notify Yucca before the six-month mark. The general thirty-day post-mark claim window does not apply to twelve-month plans. [4]

There are material differences between the FAQ and the detailed terms. The FAQ calls for twenty of twenty-six weekly weights and says pausing ends eligibility. The detailed terms describe eighteen of twenty-four weeks and say paused weeks move the six-month mark. Get the applicable requirements in writing before relying on the promise. Do not silently combine the more favorable pieces from the two descriptions. [4] [5]

Ordinary refunds stop at prescription issuance

Yucca charges at checkout before clinical review. A declined prescription produces a full refund, and the ordinary policy permits cancellation before the prescription is issued. Once issued, the order is final even before shipping. For renewals, cancellation is requested at least seven days before the scheduled date. The same policy preserves a refund while processing has begun but no prescription has been issued. [3]

These rules make order status more important than a shipment estimate. The conditional six-month promise is a separate claim route with its own records and deadlines. Logging a dose within seventy-two hours and keeping the required weight record are practical obligations, not incidental paperwork. A reader who does not want that burden should not budget as though reimbursement is assured. [4]

Compare the supplied product as well as the payment

The dedicated medication pages call the preparations compounded and not FDA-approved. They also distinguish published branded-drug trials from results established for these preparations. That is a useful disclosure. It leaves the clinician responsible for explaining the actual prescription and alternatives; a shared ingredient name or an attractive plan cannot supply that explanation. [1] [2]

I would compare Yucca further when the selected invoice, prescription and renewal terms fit the buyer and the guarantee questions are resolved. For approved branded access or insurance help, use a service built around that job instead. The practical attraction here is a defined cash-pay package. Its value should survive a comparison that assigns no guaranteed dollar value to a conditional refund.

Understanding the cost

Current semaglutide listings: $89 monthly, $450 every six months, or $828 every twelve months ($69/month equivalent). Tirzepatide: $139 monthly, $750/six months, or $1,428/twelve months. These are current advertised plans; confirm the selected prescription, applicable promotion and actual billing agreement.

Build your cost estimate

Sources

  1. Yucca semaglutide: current billing options and included services
  2. Yucca tirzepatide: current billing intervals and prices
  3. Yucca refunds and cancellations: prescription cutoff and renewal timing
  4. Yucca plan offers: price-lock limits and complete six-month promise conditions
  5. Yucca FAQ: access, prescribing and general promise summary

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.